iMRS Prime Receives Health Canada Class II Approval

Health Canada headquarters building in Ottawa, related to iMRS Prime Class II approval.

iMRS Prime Now Holds Health Canada Class II Approval

We’re pleased to announce that the iMRS Prime has officially been granted Health Canada Class II approval, marking an important step forward for iMRS Prime availability and integration across Canada.

This regulatory status confirms that the iMRS Prime meets the requirements for import, distribution, and use within the Health Canada Class II device framework. It also allows increased collaboration with healthcare providers, clinics, and organizations that operate within regulated Canadian environments.


What This Approval Means

  • The iMRS Prime is now registered as a Class II device in Canada.

  • It may now be made available to facilities that require regulatory authorization.

  • It strengthens product credibility and transparency within Canadian standards.

This aligns the iMRS Prime with other international regulatory recognitions and further positions it as one of the most advanced PEMF systems available in North America.


A Milestone for the PEMF Community

For users, practitioners, and future owners of the system, this milestone represents:

✔ Increased confidence in manufacturing and compliance
✔ Greater adoption potential in professional settings
✔ A positive step toward wider mainstream acceptance

While individual experiences with PEMF systems can vary, regulatory approvals like this help create a foundation for future growth, education, and public recognition.


Health Canada Certificate

Below is the official Health Canada Class II certificate for the iMRS Prime:

iMRS Prime Health Canada Class II Approval Certificate

Official Health Canada Class II Certificate for the iMRS Prime PEMF System.

Health_Canada_Certificate_iMRS_prime


📌 Learn More About the iMRS Prime System

For a full overview of models, features, and technology architecture, you may visit our main iMRS Prime System Hub:

🔗 View iMRS Prime Hub Page →


This announcement reflects Canadian regulatory classification for the iMRS Prime. It is provided for informational purposes only and does not imply therapeutic claims or usage guidelines.